A B S T R A C T T lymphocytes from control subjects were separated into subsets using monoclonal antibodies of the OKT series and complement lysis and analyzed for ecto-5'-nucleotidase activity both by quantitative radiochemical assay and a histochemical stain. T cells from 15 control subjects contained 54±4% OKT4' (helper/inducer) cells and 32±3% OKT8' (cytotoxic/suppressor) cells. Total T cell ecto-5'-nucleotidase activity was 10.9±2.1 nmol/h per 10' cells with 25±7% positive by histochemical stain. Ecto-5'-nucleotidase activity in OKT4-enriched populations was 5.43±1.8 nmol/h per 10' cells with 14±2% positive by histochemical stain; that in OKT8-enriched populations was 17.1±5.9 nmol/h per 106 cells with 35±8% positive by histochemical stain.
Two of four patients with congenital agammaglobulinemia and four of seven patients with common variable immunodeficiency had decreased proportions of OKT4' T cells with corresponding increases in the proportions of OKT8' T cells (OKT4/OKT8 = 0.60 to 1.0 as compared with 1.7±0.2 for control subjects). All munodeficiency also had low T cell ecto-5'-nucleotidase activity (<5.5 nmol/h per 10" cells). Ecto-5'-nucleotidase activity in OKT4-enriched populations isolated from four patients with low total T cell activity was 2.85±0.90 nmol/h per 106 cells with 10±4% positive by histochemical stain; that in OKT8-enriched populations was 6.82±1.7 nmol/h per 106 cells with 7.5±3% positive by histochemical stain. Thus, the number of ecto-5'-nucleotidase positive cells is decreased, especially in the OKT8' subpopulation, and the low total T cell ecto-5'-nucleotidase activity seen in these patients is due to fewer positive cells rather than to substantially less activity per cell.
Our data indicate that ecto-5'-nucleotidase activity defines two subpopulations of T lymphocytes (ecto-5'-nucleotidase positive and negative), the proportions of which are markedly altered in many patients with hypogammaglobulinemia. In preliminary studies with seven patients, increased numbers of ecto-5'-nucleotidase negative T cells appeared to correlate with increased suppressor T cell activity toward in vitro immunoglobulin synthesis. Therefore, ecto-5'-nucleotidase may be a useful cell surface marker in the study of imbalances of regulatory T cell subsets in patients with antibody synthesis disorders. INTRODUCTION Decreased activity of specific enzymes in the purine catabolic pathway leads to profound human immunodeficiency diseases. Deficiency of lymphocyte aden-osine deaminase (ADA)' activity causes severe combined immunodeficiency (1); deficiency of purine nucleoside phosphorylase (PNP) activity leads to an isolated T cell defect (2) . Both enzyme deficiencies are the results of mutations in the structural genes coding for the missing enzymes, leading to losses of activity in all tissues (3) (4) (5) (6) (7) . In both cases, the patients' loss of immune function can be directly attributed to alterations in purine ribo-and/or deoxyribonucleoside metabolism (8) (9) (10) (11) (12) (13) (14) (15) . A deficiency of a third enzyme in the purine catabolic pathway, ecto-5'-nucleotidase (ecto-5'-NT), which is located on the external surface of the plasma membrane, has been reported in the lymphocytes of all patients with congenital agammaglobulinemia (CAG) (16, 17) and the majority of patients with common variable immunodeficiency (CVI, or adult onset hypogammaglobulinemia) (18) . Unlike deficiencies of ADA and PNP, the molecular and/or cellular basis of ecto-5'-NT deficiency is not well understood. Ecto-5'-NT deficiency is restricted to lymphocytes, does not appear to be the consequence of a structural gene mutation, and causes no detectable aberrations in purine metabolism (19) .
Because human peripheral blood lymphocytes are not homogeneous with respect to ecto-5'-NT activity (17, 20, 21) , the deficiency in patients with CAG and CVI can be understood only by studying purified lymphocyte subpopulations. Ecto-5'-NT deficiency in CAG and CVI may be partially explained by an absence of mature B lymphocytes, which normally have threeto fivefold higher ecto-5'-NT activity than total T cell preparations (17, 20, 22) . However, the majority of patients with CAG (17, 23) and CVI (24) also have decreased (one-third to one-half of normal) ecto-5'-NT activity in total T cell preparations. We have previously shown (21) that Ty cells (T cells with Fc receptors for IgG) have only one-third the ecto-5'-NT activity of T$ cells (T cells with Fc receptor for IgM); however, little is known regarding ecto-5'-NT activity in T cell subsets defined by the monoclonal antibodies OKT4 (helper/inducer) and OKT8 (cytotoxic/suppressor) (25) . The experiments described here were designed to determine: (a) whether OKT4+ and OKT8+ T cells isolated from normal individuals have different levels of ecto-5'-NT activity, and (b) whether the low T cell ecto-5'-NT activity in CAG and CVI patients could be explained by altered proportions of regulatory T cell subsets. In addition, we have performed preliminary experiments to determine whether low T cell ecto-5'-NT activity in patients with CAG and CVI [34] ) followed by C' served as the control. All isolated T cell subsets were stained with the appropriate monoclonal antibodies and analyzed with the FACS IV to determine the purity of the T cell subsets. For this purpose, cells were first stained with Fl-F(ab')2 goat anti-mouse Ig to determine the percentage of cells stained with monoclonal antibodies, but not lysed by C'. In the OKT4-enriched preparation, for example, this procedure would detect residual OKT8+ and OKM1+ T lymphocytes. A second preparation of cells was then stained with the monoclonal antibody that defines the subset for which they were enriched, i.e. OKT4, in the case of OKT4-enriched cells. (39) .
RESULTS
Characterization of total T cells from control subjects and CAG and CVI patients. Total T lymphocytes from control subjects and patients with CAG and CVI were characterized with respect to ecto-5'-NT activity and the percentages of cells bearing Fc receptors for IgG (T-y cells) and the T4 and T8 antigens (Table I ). All four CAG patients studied had <55% of normal ecto-5'-NT activity in their total T lymphocytes. There was a great variation in ecto-5'-NT activity in total T lymphocytes isolated from patients with CVI, with individual values from 25 to 100% of normal. There were no obvious correlations between the degree of enzyme deficiency and age of onset or severity of disease with the CVI patients. Total T lymphocytes from control subjects contained 8.8±3% Ty cells, 54±4% OKT4' cells, and 32±3% OKT8' cells, with a ratio of OKT4'/OKT8' cells of 1.7±0. Adenosine deaminase and purine nucleoside phosphorylase activities in OKT4-enriched and OKT8-enriched lymphocyte subpopulations. In order to determine whether T cell subsets differ in other enzymes in the purine catabolic pathway, adenosine deaminase and purine nucleoside phosphorylase activities were measured in OKT4-and OKT8-enriched lymphocyte populations isolated from two healthy donors. There was no significant difference in either enzyme activity (Table III) . Thus none of the patients had defective helper-T cell activity.
Suppressor activity of the patients' T cells was assessed by comparing the quantities of IgM and IgG synthesized by co-cultures of patients and control PBM (5 X 105 cells of each) in response to PWM with the quantities of IgM and IgG synthesized by individual cultures of patient PBM and control PBM as described by Waldmann (40) . In three of the seven patients studied (9-11) co-cultures of patient and control PBM synthesized >70% of the expected quantities of 1gM and IgG (Table III) . These patients were judged to have normal T suppressor activity. In the other four patients (2, 4, 6, 8) , however, the quantities of IgM and IgG synthesized in co-cultures was suppressed by 74 to >95% as compared to that synthesized in individual cultures of patient and control PBM. Thus, these four patients were considered to have increased suppressor T cell activity. In all four cases, additional co-culture experiments with purified T cells showed that the increased suppressor activity was due to radiation-sensitive (2,000 rad) T cells.
The patients' T cell ecto-5'-NT activity was compared with our evaluation of their T helper and suppressor activity toward in vitro immunoglobulin biosynthesis. The three patients with normal T cell ecto-5'-NT activity (9-11) had normal helper and suppressor function, while all four patients with low T cell ecto-5'-NT activity (2, 4, 6, 8) had increased T suppressor activity. 10 .1±3.5 nmol/ h per 106 cells for control subjects) in total T cell preparations from all four patients with CAG and three of seven patients with CVI, confirming both our earlier work (17) and the work of Edwards (23) and Webster (24) . In no case could low T cell ecto-5'-NT activity be explained by increased proportions of T cell subpopulations normally low in ecto-5'-NT activity (i.e., Ty and OKT4' T cells). All of the patients studied had normal or even decreased percentages of Ty cells; two of four patients with CAG and four of seven patients with CVI had decreased percentages of OKT4' T cells and corresponding increases in percentages of OKT8' T cells to yield OKT4/OKT8 ratios of 0.60 to 1.0 (as compared to 1.7±0.2 for control subjects), similar to those reported by Reinherz et al. (44) . In four patients, low total T cell ecto-5'-NT activity was due to reduced numbers of ecto-5'-NT positive cells, especially in the OKT8+ population, rather than to substantially less ecto-5'-NT activity per cell. In OKT4+-enriched preparations from these patients, ecto-5'-NT activity was The mechanism responsible for altered proportions of ecto-5'-NT positive and negative T cells in hypogammaglobulinemia is unknown. It is, however, unlikely to be secondary to chronic infections since it was found in patient 3 at birth and in patient 8 who is in good health. Ecto-5'-NT deficiency cannot be a consequence of immunoglobulin replacement therapy (as has been suggested for decreased PWM responses in nonimmunodeficient children treated with gammaglobulin [47] ), since is was detected in two of our patients before the initiation of treatment. Although ecto-5'-NT activity is a marker for T lymphocyte differentiation (22, 23, 48) , with thymocytes having virtually absent activity, it is unlikely that low numbers of T cells with ecto-5'-NT activity in CAG and CVI patients can be explained merely by a block in T cell maturation. The T cells of none of our patients reacted with the monoclonal antibodies OKT10 or OKT6 (data not shown), both of which recognize thymocyte antigens (34) . Furthermore, none of the patients suffered from a clinical deficit in T cell function as would be expected with a predominance of immature T lymphocytes.
In preliminary studies with seven patients, increased proportions of ecto-5'-NT negative T cells correlated with increased suppressor T cell activity toward PWMdriven in vitro immunoglobulin biosynthesis. These results suggest that human suppressor T cells belong to the ecto-5'-NT negative subpopulation. Confirmation of this hypothesis awaits functional studies on purified preparations of ecto-5'-NT positive and negative T cells and unfortunately no methods are yet available for performing these separations. It is important to note that the proportions of T cells recognized by monoclonal antibodies OKT4 and OKT8 did not always correctly predict the functional defects in our patients' T cells. Patients 2 and 8 had relatively normal ratios of OKT4' to OKT8' T cells, yet showed increased suppressor activity; patient 11 had a distinctly abnormal OKT4'/OKT8' ratio, yet normal helper and suppressor activity. These results are consistent with the accumulating evidence that although the monoclonal antibodies OKT4 and OKT8 define T cell subsets enriched for help and suppression, respectively, of PWM-driven immunoglobulin synthesis in healthy adult donors (25, 49) , the antigens recognized by these antibodies do not always correlate with function during development or in some patients with immunodeficiency disease. In cord blood (50) , suppression is found in the OKT4', rather than the OKT8' population and Reinherz recently (51) described a patient with a functional helper T cell defect, but normal numbers of OKT4' cells. There is also increasing evidence that OKT4' and OKT8' cells are heterogeneous with respect to both function and cell surface determinants (50) (51) (52) (53) (54) . Our data demonstrate that ecto-5'-NT activity defines a subpopulation of T cells that overlaps the subpopulations defined by OKT4 and OKT8 and that the proportions of ecto-5'-NT positive and negative T cells is markedly altered in many patients with CAG and CVI. Since increased numbers of ecto-5'-NT negative cells appear to correlate with enhanced suppressor activity in the seven patients examined in our studies, ecto-5'-NT activity may define functional subsets of T cells and thus prove to be a useful T cell surface marker in the study of regulatory T cell subset imbalances leading to hypogammaglobulinem ia.
